… 000 in respect of cost;cost-effectiveness ratio was between $ 9 … elderly was not
considered cost-effectiveness.CONCLUSIONS:… pneumococcal polysaccharide vaccine;Cost-effectiveness …

… Moreover, the incidence of invasive pneumococcal disease, the pneumococcal colonization,
and the pneumococcal resistance for antibiotics are all decreased significantly when …

… 7,PCV7)和13价肺炎链球菌结合疫苗(pneumococcal conjugate vaccine 13, PCV13)等的接种
,肺炎链… Streptococcus pneumoniae infection and severity in pediatric lobar pneumonia[J]. J …

… Conclusions PPV23 vaccination in the HIV-1 infected persons
isconducivetoreducingtheincidenceofopportunisticpulmonaryinfection,andhasagoodsafetyand …

… related infectious diseases. Again, herd protection has played an important role in public
health practices. With the increasing interests in estimating the vaccine herd protection, we …

… 1 dose of PPV23 vaccination were selected as revaccination group and those without history
of pneumococcal vaccine immunization were selected as the first vaccination group. One …

… Streptococcus Pneumoniae diseases in Chinese children: … Responses to a conjugate
pneumococcal vaccine in preterm … Cost effectiveness of pneumococcal conjugate vaccine: …

… The models of different serotypes of Streptococcus pneumoniae infection were established
to evaluate the immunoprotective effect of target proteins used alone or in combination. …

… pneumococcal disease control and prevention and to provide appropriate evidences of
pneumococcal vaccine … people who are engaged in public health and immunization vaccination. …